A Study of CTD402 in T-ALL/LBL Patients
A Study of CTD402 in T-ALL/LBL Patients
Recruiting · NCT07070219 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of CTD402 in T-ALL/LBL Patients | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT07070219 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imviva Bio | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | United States | 178 |
| Mayo Clinic - Rochester | Rochester | United States | 59 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 2 |
| Montefiore Einstein Comprehensive Cancer Center | The Bronx | United States | 5 |
| Royal Prince Alfred | Sydney | Australia | 2 |
| Sarah Cannon Research Insitute | Nashville | United States | 2 |
| Stanford University | Palo Alto | United States | 161 |
| University of Chicago | Chicago | United States | 312 |